Literature DB >> 8114705

Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells.

M F Kulesz-Martin1, B Lisafeld, H Huang, N D Kisiel, L Lee.   

Abstract

We previously demonstrated that a wild-type alternatively spliced p53 (p53as) RNA exists in mouse cultured cells and normal mouse tissues at approximately 25 to 33% of the level of the major p53 RNA form. The alternative RNA transcript is 96 nucleotides longer than the major transcript as a result of alternative splicing of intron 10 sequences. The protein expected to be generated from the p53as transcript is 9 amino acids shorter than the major p53 protein and has 17 different amino acids at the carboxyl terminus. We report here that p53as protein exists in nontransformed and malignant epidermal cells and is localized to the nucleus. In addition, p53as protein is preferentially expressed during the G2 phase of the cell cycle and in cells with greater than G2 DNA content compared with the major p53 protein, which is preferentially expressed in G1. The p53as immunoreactivity is elevated and shifted to the G1 phase of the cell cycle following actinomycin D treatment of nontransformed cells but not malignant cells. In view of the dimerization and tetramerization of p53 protein which may be necessary for its DNA binding and transcriptional activation activities, the presence of p53as protein in cells has important implications for understanding the physiological function(s) of the p53 gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114705      PMCID: PMC358528          DOI: 10.1128/mcb.14.3.1698-1708.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Retinoic acid enhancement of an early step in the transformation of mouse epidermal cells in vitro.

Authors:  M Kulesz-Martin; L Blumenson; B Lisafeld
Journal:  Carcinogenesis       Date:  1986-09       Impact factor: 4.944

2.  Monoclonal antibody analysis of p53 expression in normal and transformed cells.

Authors:  J W Yewdell; J V Gannon; D P Lane
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 3.  Structural aspects of the p53 protein in relation to gene evolution.

Authors:  T Soussi; C Caron de Fromentel; P May
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

4.  Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.

Authors:  D Wolf; N Harris; N Goldfinger; V Rotter
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

5.  Immunologically distinct p53 molecules generated by alternative splicing.

Authors:  N Arai; D Nomura; K Yokota; D Wolf; E Brill; O Shohat; V Rotter
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

6.  Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes.

Authors:  J Milner
Journal:  Nature       Date:  1984 Jul 12-18       Impact factor: 49.962

7.  Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

Authors:  D Wolf; N Harris; V Rotter
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

8.  Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen.

Authors:  M Oren; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Mouse cell clones for improved quantitation of carcinogen-induced altered differentiation.

Authors:  M Kulesz-Martin; M A Yoshida; L Prestine; S H Yuspa; J S Bertram
Journal:  Carcinogenesis       Date:  1985-09       Impact factor: 4.944

10.  Precise epitope mapping of the murine transformation-associated protein, p53.

Authors:  A Wade-Evans; J R Jenkins
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  23 in total

1.  Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.

Authors:  F Janus; N Albrechtsen; U Knippschild; L Wiesmüller; F Grosse; W Deppert
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation.

Authors:  Min Yang; Jack Wu; Si-Hung Wu; An-Ding Bi; D Joshua Liao
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

3.  Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.

Authors:  Y Wu; H Huang; Z Miner; M Kulesz-Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  The C terminus of p53 family proteins is a cell fate determinant.

Authors:  Kelly Lynn Harms; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 5.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

6.  Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids.

Authors:  L Wu; J H Bayle; B Elenbaas; N P Pavletich; A J Levine
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

7.  The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells.

Authors:  N Almog; R Li; A Peled; D Schwartz; R Wolkowicz; N Goldfinger; H Pei; V Rotter
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

8.  DNA binding specificity of proteins derived from alternatively spliced mouse p53 mRNAs.

Authors:  Z Miner; M Kulesz-Martin
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

9.  Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53.

Authors:  K Will; G Warnecke; S Bergmann; W Deppert
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

10.  p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes.

Authors:  V A Tron; M J Trotter; L Tang; M Krajewska; J C Reed; V C Ho; G Li
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.